AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2022
Mar 7, 2022
34491_dirs_2022-03-07_d41fbc9e-8491-4c9b-90d5-e877eb55f8ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-03-03
Reporting Person: List Alan (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | Employee Stock Option (Right to Buy) | $4.08 | A | 140299 | Acquired | 2032-03-02 | Common Stock (140299) | Direct |
| 2022-03-03 | Restricted Stock Units | $ | A | 88343 | Acquired | Common Stock (88343) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable
vesting dates.
F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.